3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
3
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
5
Genitourinary
1
CNS
1
Conditions
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiotherapy, Intensity-Modulated
3
Temozolomide
2
pyrotinib
1
Vinorelbine
1
Radiation Dose Hypofractionation
1
Pharmaceutical Preparations
1
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
pyrotinib
×
CNS
×
Clear all
NCT03933982
2019-05-29
Pyrotinib
ChineseAMS
Phase 2
Unknown
30 enrolled